Tuesday, March 6, 2007
VentiRx Raises $28.9M
San Diego-based VentiRx Pharmaceuticals announced today that it has raised $28.9M in funding for the firm's treatments for cancer and infection, respiratory, and autoimmune diseases. The funding came from Frazier Healthcare Ventures, ARCH Venture Partners and Domain Associates. $26.6M of the investment came in the firm's Series A, the other $2.3M was part of a seed funding. More information »
Support Our Coverage Of SoCal's Tech Ecosystem!
Tap into Southern California's growing tech ecosystem, by signing up for a two week free trial membership. Find new tech customers, find high tech startups and jobs, find venture funding, help support our news coverage!Learn More